NDC 71288-554
Ganirelix Acetate
Ganirelix Acetate
Ganirelix Acetate is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is Ganirelix Acetate.
| Product ID | 71288-554_3db91dee-b161-403f-b616-1add2d82040d |
| NDC | 71288-554 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ganirelix Acetate |
| Generic Name | Ganirelix Acetate |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2022-06-06 |
| Marketing Category | ANDA / |
| Application Number | ANDA214996 |
| Labeler Name | Meitheal Pharmaceuticals Inc. |
| Substance Name | GANIRELIX ACETATE |
| Active Ingredient Strength | 250 ug/.5mL |
| Pharm Classes | Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |